Literature DB >> 7746404

Lack of association of apolipoprotein E allele epsilon 4 with late-onset Alzheimer's disease among Finnish centenarians.

E Sobel1, J Louhija, R Sulkava, Z Davanipour, K Kontula, H Miettinen, M Tikkanen, K Kainulainen, R Tilvis.   

Abstract

No association between Alzheimer's disease (AD) and apolipoprotein E type epsilon 4 (ApoE epsilon 4) phenotype was found among centenarians in Finland (N = 179). The data are based on ascertainment of all centenarians in Finland in 1991. All examinations were conducted during 1991. The diagnoses of dementia and AD were based on clinical grounds, conforming to DSM-III-R and NINCDS-ADRDA criteria. The percentage of ApoE epsilon 4 alleles among the centenarians was 8.7% (31 of 358 alleles). This is significantly lower than percentages found in younger Finnish populations. Thirty (16.8%) of the 179 centenarians were epsilon 4 allele carriers. One hundred fifty-one (84.4%) of the centenarians were women. Twenty-eight (18.5%) of the women had at least one epsilon 4 allele, as did two (7.1%) of the men. The prevalence of clinically diagnosed AD was 26.8%; 44% of the subjects were cognitively normal, 23% had signs of cognitive decline or at most mild dementia (with no differential diagnosis), and 6% had a dementia clinically diagnosed as being due to some cause other than AD. For AD cases versus cognitively normal subjects, the odds ratio associated with being a carrier of the epsilon 4 allele was 1.34 (p = 0.64; 95% CI = [0.5, 3.3]). Among women, the odds ratio was 0.99 (p = 1.0; 95% CI = [0.4, 2.6]). There were fewer, but not significantly so, epsilon 4 carriers among subjects with cognitive decline or at most mild dementia (12.2%) than there were among the cognitively normal subjects (16.5%). The AD patients had no evidence of difficulty standing on a flat stationary surface unless the surface suddenly moved.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7746404     DOI: 10.1212/wnl.45.5.903

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  22 in total

1.  Exceptional brain aging in a rural population-based cohort.

Authors:  Jeffrey Kaye; Yvonne Michael; James Calvert; Marjorie Leahy; Debbie Crawford; Patricia Kramer
Journal:  J Rural Health       Date:  2009       Impact factor: 4.333

2.  Dementia incidence continues to increase with age in the oldest old: the 90+ study.

Authors:  María M Corrada; Ron Brookmeyer; Annlia Paganini-Hill; Daniel Berlau; Claudia H Kawas
Journal:  Ann Neurol       Date:  2010-01       Impact factor: 10.422

Review 3.  Epidemiology of the dementias: recent developments and new approaches.

Authors:  C M van Duijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

4.  A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype.

Authors:  H Payami; H Grimslid; B Oken; R Camicioli; G Sexton; A Dame; D Howieson; J Kaye
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

5.  Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease.

Authors:  Neena Theresa Kumar; Knut Liestøl; Else Marit Løberg; Henrik Mikael Reims; Jan Mæhlen
Journal:  Virchows Arch       Date:  2015-04-22       Impact factor: 4.064

6.  Identifying families with likely genetic protective factors against Alzheimer disease.

Authors:  J M Silverman; C J Smith; D B Marin; S Birstein; M Mare; R C Mohs; K L Davis
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

7.  Effects of the APOE ε4 allele and education on cognitive function in Japanese centenarians.

Authors:  Yoshiko Lily Ishioka; Yasuyuki Gondo; Noriyuki Fuku; Hiroki Inagaki; Yukie Masui; Michiyo Takayama; Yukiko Abe; Yasumichi Arai; Nobuyoshi Hirose
Journal:  Age (Dordr)       Date:  2016-08-24

8.  Deaths attributable to Alzheimer's disease in the United States.

Authors:  D C Ewbank
Journal:  Am J Public Health       Date:  1999-01       Impact factor: 9.308

9.  Apolipoprotein E and familial longevity.

Authors:  Nicole Schupf; Sandra Barral; Thomas Perls; Anne Newman; Kaare Christensen; Bharat Thyagarajan; Michael Province; Winifred K Rossi; Richard Mayeux
Journal:  Neurobiol Aging       Date:  2012-10-05       Impact factor: 4.673

10.  Apolipoprotein E genotype, dementia, and mortality in the oldest old: the 90+ Study.

Authors:  María M Corrada; Annlia Paganini-Hill; Daniel J Berlau; Claudia H Kawas
Journal:  Alzheimers Dement       Date:  2012-11-02       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.